Nebulizer manufacturer PARI announced that it has acquired equine nebulizer maker Nortev in a deal that the company suggested “opens attractive synergy potential.” Nortev will continue to operate independently, the company said. According to PARI, Nortev also sells nebulizers for small pets in addition to its Flexineb device for horses, which is sold in more than 30 countries.
PARI CEO Arne W. Dirks commented, “Our goal is to establish PARI’s more than 100 years of experience in inhalation therapy in the field of animal inhalation. With Nortev we have found a company that, like us at PARI, develops and sells innovative inhalation devices with the highest quality standards. Together, we can develop new inhalation therapies that benefit horses and small animals with respiratory diseases – and thus also their owners.”
Nortev CEO and Managing Director Gavan O’Sullivan said, “I look forward to further developing our Flexineb equine nebulizer under the PARI umbrella. There will be no changes for our Flexineb customers as a result of the acquisition. With PARI’s support, we will enhance our core vision of continuous improvement and innovation in animal respiratory healthcare.”
Read the PARI press release.
